Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer
about
Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis.Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.Modulation of pancreatic cancer chemoresistance by inhibition of TAK1Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells.Apoptotic pathways in pancreatic ductal adenocarcinomaInhibitor of apoptosis proteins and apoptosis.IAP proteins as targets for drug development in oncologyHelicobacter pylori Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis.A critical assessment of the methodologies to investigate the role of inhibition of apoptosis in rodent hepatocarcinogenesis.Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication.Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.Translation of cIAP2 mRNA is mediated exclusively by a stress-modulated ribosome shunt.Inhibitors of apoptosis: clinical implications in cancer.Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas.
P2860
Q33636816-10F83A21-1656-4486-B1BD-2E6B054A55CCQ33841579-083C37ED-5B6B-4467-A81E-31AD82A1615FQ34542571-179C5F68-05E6-4DB0-84E8-B803613A6123Q34960600-817F0870-D7F4-49D2-858D-EC076AF71F2DQ35143975-20ADF447-27B8-4D54-925C-D9946CE05775Q36094941-EB7A2911-74CE-4C9D-9A2A-4AB2E7C5EF2CQ36835642-9667DF83-F759-4E6F-80EC-B07262118F2FQ37134050-F3D08875-29BA-4848-8B71-DA60511D978DQ37209606-BC912557-35A6-4C9A-B4B3-4605FC00A2BFQ37573924-70F3EE02-1375-4647-9B7A-E4941686C65BQ38327212-28D6F276-4B5F-49AD-A301-E2396435A861Q38815842-EAEB45D8-0386-4FB2-971A-0CA2AC63CCACQ39171781-7CCF387E-C4F5-49E3-A73D-E914EC3D31A1Q42147260-8513AE50-F178-478D-BC66-50916C3534E5Q43077403-83FA2683-6267-4DAB-B77C-DB6991DA52BBQ47607136-40D47616-A022-4756-B42E-BA961F7B1EEAQ48450830-D071C9DD-D7D5-4FCE-8E77-3094E272A901
P2860
Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Overexpression of cellular inh ...... ogression of pancreatic cancer
@ast
Overexpression of cellular inh ...... ogression of pancreatic cancer
@en
type
label
Overexpression of cellular inh ...... ogression of pancreatic cancer
@ast
Overexpression of cellular inh ...... ogression of pancreatic cancer
@en
prefLabel
Overexpression of cellular inh ...... ogression of pancreatic cancer
@ast
Overexpression of cellular inh ...... ogression of pancreatic cancer
@en
P2093
P2860
P50
P356
P1476
Overexpression of cellular inh ...... ogression of pancreatic cancer
@en
P2093
Frank Bergmann
Ivane Abiatari
Jörg Kleeff
Peter Schirmacher
Wilfried Roth
P2860
P304
P356
10.1136/JCP.2006.038257
P407
P577
2006-06-14T00:00:00Z